西安泰科(ke)(ke)(ke)邁醫藥(yao)(yao)(yao)(yao)(yao)科(ke)(ke)(ke)技股份有限公司成立于2011年(nian)(nian)(nian),是一家(jia)(jia)專(zhuan)(zhuan)業(ye)(ye)從事藥(yao)(yao)(yao)(yao)(yao)品(pin)研(yan)(yan)(yan)(yan)(yan)究和(he)(he)技術(shu)開(kai)發(fa)(fa)的高新(xin)技術(shu)企(qi)業(ye)(ye)。地址位于西安市高新(xin)區創業(ye)(ye)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)園(yuan)B座,是陜西省政府批準的博(bo)士后(hou)創新(xin)基(ji)地、西安交通大(da)學(xue)(xue)和(he)(he)西北大(da)學(xue)(xue)博(bo)士后(hou)人才培(pei)養基(ji)地;是清華大(da)學(xue)(xue)、中(zhong)國藥(yao)(yao)(yao)(yao)(yao)科(ke)(ke)(ke)大(da)學(xue)(xue)、沈陽(yang)藥(yao)(yao)(yao)(yao)(yao)科(ke)(ke)(ke)大(da)學(xue)(xue)和(he)(he)陜西醫藥(yao)(yao)(yao)(yao)(yao)集(ji)團(tuan)等(deng)(deng)數十家(jia)(jia)科(ke)(ke)(ke)研(yan)(yan)(yan)(yan)(yan)院(yuan)所的合作(zuo)伙伴;與美(mei)國、加拿大(da)、葡萄牙、塞浦路(lu)斯等(deng)(deng)國家(jia)(jia)建立了海外技術(shu)合作(zuo)關(guan)系。主營業(ye)(ye)務(wu)(wu):抗腫瘤新(xin)藥(yao)(yao)(yao)(yao)(yao)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa),化(hua)學(xue)(xue)仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa),仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)一致性(xing)評價(jia)(jia)技術(shu)服(fu)務(wu)(wu),中(zhong)藥(yao)(yao)(yao)(yao)(yao)開(kai)發(fa)(fa)及技術(shu)服(fu)務(wu)(wu),藥(yao)(yao)(yao)(yao)(yao)物臨床研(yan)(yan)(yan)(yan)(yan)究服(fu)務(wu)(wu)。7年(nian)(nian)(nian)來以藥(yao)(yao)(yao)(yao)(yao)品(pin)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)為己任,以打造成國內(nei)一流(liu)的藥(yao)(yao)(yao)(yao)(yao)物研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)機構(gou)和(he)(he)專(zhuan)(zhuan)業(ye)(ye)的藥(yao)(yao)(yao)(yao)(yao)品(pin)服(fu)務(wu)(wu)商為目標。在(zai)癌癥、心腦血管、腸胃(wei)道、免(mian)疫(yi)力低下、神(shen)經系統(tong)等(deng)(deng)疾病(bing)領域(yu),應用納米(mi)遞(di)釋技術(shu)、緩(huan)(huan)控釋技術(shu)、逆向(xiang)工(gong)程技術(shu)先后(hou)為100余戶企(qi)業(ye)(ye)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)申報注冊(ce)(ce)中(zhong)藥(yao)(yao)(yao)(yao)(yao)、化(hua)藥(yao)(yao)(yao)(yao)(yao)仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)、保健品(pin)等(deng)(deng)藥(yao)(yao)(yao)(yao)(yao)品(pin)200多(duo)個。公司立足于化(hua)藥(yao)(yao)(yao)(yao)(yao)仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)開(kai)發(fa)(fa)、仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)一致性(xing)評價(jia)(jia)、尤其是對緩(huan)(huan)控釋類藥(yao)(yao)(yao)(yao)(yao)物的仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)開(kai)發(fa)(fa)有豐富經驗,可(ke)以為客(ke)戶提供(gong)仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)及仿(fang)(fang)(fang)制(zhi)藥(yao)(yao)(yao)(yao)(yao)一致性(xing)評價(jia)(jia)藥(yao)(yao)(yao)(yao)(yao)學(xue)(xue)研(yan)(yan)(yan)(yan)(yan)究、BE試(shi)驗與藥(yao)(yao)(yao)(yao)(yao)品(pin)注冊(ce)(ce)的一站式研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)服(fu)務(wu)(wu)。歷年(nian)(nian)(nian)來累積申報發(fa)(fa)明專(zhuan)(zhuan)利147項,PCT專(zhuan)(zhuan)利5項,授權29項。在(zai)國家(jia)(jia)級刊物上發(fa)(fa)表論文(wen)130多(duo)篇,SCI論文(wen)11篇,參與編纂(zuan)專(zhuan)(zhuan)著多(duo)篇。每(mei)(mei)年(nian)(nian)(nian)研(yan)(yan)(yan)(yan)(yan)發(fa)(fa)投(tou)入占比達80%以上,每(mei)(mei)年(nian)(nian)(nian)技術(shu)成果以30%的速(su)度遞(di)增。
泰科邁醫藥(yao)(yao)(yao)的價值不(bu)是(shi)取(qu)決于其(qi)研(yan)(yan)(yan)發(fa)能力(li)和(he)銷售水(shui)平,而是(shi)取(qu)決于滿足市場需(xu)求的數量和(he)質量。依(yi)托高(gao)超的醫藥(yao)(yao)(yao)逆向工程技術、緩控釋技術、載藥(yao)(yao)(yao)修(xiu)飾(shi)技術、臨(lin)床研(yan)(yan)(yan)究(jiu)技術等,先后為步(bu)長制(zhi)藥(yao)(yao)(yao)、內(nei)蒙惠豐(feng)制(zhi)藥(yao)(yao)(yao)、新(xin)疆希望制(zhi)藥(yao)(yao)(yao)、福建恵天(tian)生物(wu)制(zhi)藥(yao)(yao)(yao)、珠海(hai)聯邦制(zhi)藥(yao)(yao)(yao)、華(hua)東(dong)醫藥(yao)(yao)(yao)(西(xi)安)博華(hua)制(zhi)藥(yao)(yao)(yao)、煙臺(tai)魯銀藥(yao)(yao)(yao)業(ye)、陜西(xi)盤(pan)龍(long)制(zhi)藥(yao)(yao)(yao)、西(xi)安大唐(tang)制(zhi)藥(yao)(yao)(yao)、陜西(xi)方(fang)舟制(zhi)藥(yao)(yao)(yao)等60余家藥(yao)(yao)(yao)品生產企業(ye)研(yan)(yan)(yan)發(fa)和(he)成功申(shen)報新(xin)藥(yao)(yao)(yao)批件100多個。
公司建有(you)(you)(you)超1500m2的(de)藥(yao)(yao)物(wu)(wu)研究(jiu)實驗室(shi)和(he)共享2000m2的(de)藥(yao)(yao)物(wu)(wu)制(zhi)(zhi)劑中試基地,擁有(you)(you)(you)合成、分析(xi)、制(zhi)(zhi)劑、臨床(chuang)等(deng)研發和(he)中試相(xiang)配套(tao)的(de)儀器設備百余套(tao),滿足項(xiang)目研發需要。先后開發了抗(kang)腫瘤、心腦血管、糖尿病和(he)內分泌等(deng)領(ling)(ling)域的(de)藥(yao)(yao)物(wu)(wu)合成與(yu)制(zhi)(zhi)劑工藝,特別在(zai)藥(yao)(yao)物(wu)(wu)緩控(kong)釋制(zhi)(zhi)劑領(ling)(ling)域有(you)(you)(you)專長(chang)。正在(zai)開發抗(kang)腫瘤PEG修飾(shi)藥(yao)(yao)物(wu)(wu)、TKM-286和(he)TKM-383等(deng)創新藥(yao)(yao),在(zai)藥(yao)(yao)物(wu)(wu)吸(xi)收、靶向(xiang)治療、給(gei)藥(yao)(yao)安全性等(deng)方(fang)面有(you)(you)(you)重大技術突破,并不斷(duan)創新,具有(you)(you)(you)良好(hao)的(de)市場前景。
公司(si)把(ba)科(ke)研(yan)和(he)項目(mu)開發工(gong)作做為公司(si)的核(he)心,每年研(yan)發投入占比達25%以(yi)上,技術(shu)成(cheng)果以(yi)30%的速度遞增(zeng)。目(mu)前(qian)在醫藥新產品研(yan)發、新技術(shu)推廣、知識產權(quan)申報、現在信(xin)息技術(shu)應用及科(ke)學技術(shu)研(yan)究等諸多領域成(cheng)績斐然,取得了顯(xian)著的社會和(he)經濟效益。
泰科邁人秉承(cheng)民(min)族健康(kang)(kang)理念,助力(li)技(ji)術(shu)發展驅動醫(yi)藥產業(ye)升級,以持(chi)續技(ji)術(shu)創新(xin)保障醫(yi)藥產業(ye)健康(kang)(kang)發展為(wei)使(shi)命;借(jie)力(li)新(xin)藥研發、仿制(zhi)(zhi)藥一致性評價、藥品(pin)上市持(chi)有(you)人制(zhi)(zhi)度(du)政策,上市發展,立志為(wei)每(mei)一個人、每(mei)一個家庭的健康(kang)(kang)和幸福不(bu)斷(duan)求索。用業(ye)績回(hui)報(bao)股東、回(hui)報(bao)社會(hui)。